Browsing "Molecular and Biomedical Science publications" by Author Kamenecka, T.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
PreviewIssue DateTitleAuthor(s)
2011Anti-diabetic actions of a non-agonist PPARgamma ligand that blocks Cdk5-mediated phosphorylationChoi, J.; Banks, A.; Kamenecka, T.; Busby, S.; Chalmers, M.; Kumar, N.; Kuruvilla, D.; Shin, Y.; He, Y.; Bruning, J.; Marciano, D.; Cameron, M.; Laznik, D.; Jurczak, M.; Schurer, S.; Vidovic, D.; Shulman, G.; Spiegelman, B.; Griffin, P.
2007Partial agonists activate PPARγ using a helix 12 independent mechanismBruning, J.; Chalmers, M.; Prasad, S.; Busby, S.; Kamenecka, T.; He, Y.; Nettles, K.; Griffin, P.
2015Pharmacological repression of PPARγ promotes osteogenesisMarciano, D.; Kuruvilla, D.; Boregowda, S.; Asteian, A.; Hughes, T.; Garcia-Ordonez, R.; Corzo, C.; Khan, T.; Novick, S.; Park, H.; Kojetin, D.; Phinney, D.; Bruning, J.; Kamenecka, T.; Griffin, P.
2016PPARG Post-translational modifications regulate bone formation and bone resorptionStechschulte, L.; Czernik, P.; Rotter, Z.; Tausif, F.; Corzo, C.; Marciano, D.; Asteian, A.; Zheng, J.; Bruning, J.; Kamenecka, T.; Rosen, C.; Griffin, P.; Lecka-Czernik, B.
2016SR2067 reveals a unique kinetic and structural signature for PPARγ partial agonismVan Marrewijk, L.; Polyak, S.; Hijnen, M.; Kuruvilla, D.; Chang, M.; Shin, Y.; Kamenecka, T.; Griffin, P.; Bruning, J.
2015Structural mechanism for signal transduction in RXR nuclear receptor heterodimersKojetin, D.; Matta-Camacho, E.; Hughes, T.; Srinivasan, S.; Nwachukwu, J.; Cavett, V.; Nowak, J.; Chalmers, M.; Marciano, D.; Kamenecka, T.; Shulman, A.; Rance, M.; Griffin, P.; Bruning, J.; Nettles, K.